Search bioRxiv⌕ Search

Biology subjects

Eccles, M. K.

Publications and source records attributed to Eccles, M. K..

3 recordsLinked to original sources

Differential expression and modulation of presenilin-1 and presenilin-2 in neural cell lines

Presenilin proteins, the catalytic components of the {gamma}-secretase enzyme, play a key role in the pathogenesis of Alzheimers disease primarily by generating amyloid-{beta} peptides. Although often grouped together, Presenilin-1 (PS1) and Presenilin-2 (PS2) are distinct proteins that contribute differently to {gamma}-secretase activity. This study examines the differential expression of PS1 and PS2 in various neuroblastoma and microglial cell lines, along with compensatory responses following the ablation of one presenilin homologue. Using quantitative immunoblotting, we show that PS1 and PS2 expression levels vary significantly across cell types. Notably, the ablation of PS2 results in increased PS1 expression, particularly in microglial cells, highlighting the importance of PS2. Additionally, neuronal differentiation of two neuroblastoma lines, caused changes in protein expression levels resulting in similar expression profiles of PS1 and PS2, with PS2 levels being higher than PS1. Understanding PS expression profiles is crucial for distinguishing between PS1- and PS2-mediated {gamma}-secretase activity and for developing {gamma}-secretase-targeted therapeutics with improved selectivity.

cell biology↗

Presenilin homologues influence substrate binding and processing by γ-secretase: a molecular simulation study.

Presenilin homologues in the {gamma}-secretase complex play a pivotal role in substrate binding and processing, impacting {beta}-amyloid (A{beta}) peptide generation in Alzheimers disease. We conducted a molecular simulation study to determine substrate preferences between presenilin-1 (PS1) and presenilin-2 (PS2) {gamma}-secretase enzymes for amyloid precursor protein (APP) and Notch1 processing. Using homology modelling, we generated PS1- and PS2-{gamma}-secretase models bound to substrates in the A{beta}40 and A{beta}42 generation pathways and Notch1 S3 and S4 cleavage site substrates. Metadynamics simulations and binding free energy calculations were used to explore conformational ensembles and substrate preferences. PS2-{gamma}-secretase exhibited increased conformational flexibility and preferential binding energy for initiating the A{beta}42 pathway compared to PS1-{gamma}-secretase. Additionally, Notch1 exhibits a preference for binding to PS2-{gamma}-secretase over PS1-{gamma}-secretase. This study provides valuable insights into the conformational dynamics of {gamma}-secretase bound to different substrates within a cleavage pathway, improving our understanding of substrate processivity. The findings highlight the importance of considering both PS1- and PS2-{gamma}-secretase in structure-based drug design efforts, with implications for stabilizing or destabilizing specific states during APP processing.

neuroscience↗

Quantitative Comparison of Presenilin Protein Expression Reveals Greater Activity of PS2-gamma-Secretase.

{gamma}-Secretase processing of APP has long been of interest in the pathological progression of Alzheimers disease (AD) due to its role in the generation of amyloid-{beta}. The catalytic component of the enzyme are the presenilins of which there are two homologues, Presenilin-1 (PS1) and Presenilin-2 (PS2). The field has focussed on the PS1 form of this enzyme, as it is typically considered the more active at APP processing. However, much of this work has been completed without appropriate consideration of the specific levels of protein expression of PS1 and PS2. We propose that expression is an important factor in PS1- and PS2-{gamma}-secretase activity, and that when this is considered, PS1 does not have greater activity than PS2. We developed and validated tools for quantitative assessment of PS1 and PS2 protein expression levels to enable direct comparison of PS protein in exogenous and endogenous expression systems, in HEK-293 PS1 and/or PS2 knockout cells. We show that exogenous expression of Myc-PS1-NTF is 5.5-times higher than and Myc-PS2-NTF. Quantitating endogenous PS protein levels using a novel PS1/2 fusion standard we developed showed similar results. When the marked difference in PS1 and PS2 protein levels is considered, we show that compared to PS1-{gamma}-secretase, PS2-{gamma}-secretase has equal or more activity on APP and Notch1. This study has implications for understanding the PS1 and PS2 specific contributions to substrate processing, and their potential influence in AD pathogenesis.

cell biology↗